Srinivasa Reddy, PhD

Education:

  • 1984 B.Sc. (Hons) Chemistry, Department of Chemistry, Osmania UniversityHyderabad, India
  • 1986 M.Sc. (Hons) Biochemistry and Molecular Biology, University of RoorkeeIIT Roorkee, India
  • 1992 Ph.D. Comparative Biochemistry, University of California at Berkeley, Berkeley California

 ACADEMIC AFFILIATION

  • 2008 - Professor, Division of Cardiology, Department of Medicine, and Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles

 PROFESSIONAL ACTIVITIES:

  • 2004 - 2006     AHA Western Affiliate Peer Review Committee. Reviewer.
  • 2004 - Scientific Committee, International Conference on Paraoxoanses.  Member.
  • 2008 3rd International Conference on Paraoxoanses. Chair.
  • 2008 - 2012 NIH/NHLBI – Member, VCMB Study Section.
  • 2008 - Member, Jonsson Comprehensive Cancer Center
  • 2010 - NCI/NHLBI/NIDDK/NIEHS – Special Emphasis Panel Reviewer
  • 2012 - Member, Interdepartmental Program in Molecular Toxicology
  • 2013 - Chair, Department of Medicine Faculty Safety Committee
  • 2013 - 2022 Bruin Pharma, Inc.  Principal
  • 2013 - American Heart Association. Professional Member.
  • 2013 - American Society for Biochemistry and Molecular Biology. Member.
  • 2013 - Atherosclerosis, Thrombosis and Vascular Biology, Free Radical Biology & Medicine, Journal of Lipid Research, and Journal of Biological Chemistry.
  • 2014 - 2021  Advisor, Cue Inc. San Diego, CA
  • 2017 - 2020  Member, Legislative Assembly, UCLA
  • 2017 - 2020  Member, Committee on Teaching, UCLA
  • 2018 - Member, California Nano Systems Institute
  • 2019 - Scientific Advisor, Glaceum, Inc. Korea
  • 2021 - Alternate Member, MedCAP, UCLA
  • 2021 - 2024    Chief Academic Advisor (Provost), Vivekananda Yoga University, USA
  • 2023 - Member, Committee on Committees, UCLA
  • 2024 - Joint Director of Research, Vivekananda Yoga University, USA.
  • 2024 - Member of the VaYU Board of Trustees

 RESEARCH INTERESTS

For the last 30 years, I have been interested in understanding the expression, regulation, and mechanism of action, of enzymes involved in lipid and lipoprotein metabolism, and their role in the development of chronic inflammatory diseases. My research programs are primarily funded by the National Institute of Health, and I have published more than 250 peer-reviewed publications in the cell and molecular biology of oxidized phospholipids, lipoprotein metabolism and models of chronic inflammatory diseases including atherosclerosis, sepsis, pulmonary hypertension, rheumatoid arthritis, cancer, and inflammatory bowel disease (h-index 81). One of my current research interests is to combine Yoga with scientific research and develop a modern platform for evidence-based Yoga therapy and create public health awareness.